Literature DB >> 34043590

Rare loss-of-function variants in type I IFN immunity genes are not associated with severe COVID-19.

Gundula Povysil1, Guillaume Butler-Laporte2,3, Ning Shang4, Chen Wang4, Atlas Khan4, Manal Alaamery5,6, Tomoko Nakanishi2,7,8, Sirui Zhou2, Vincenzo Forgetta2, Robert Jm Eveleigh9,10, Mathieu Bourgey9,10, Naveed Aziz11, Steven Jm Jones11, Bartha Knoppers11, Stephen W Scherer11, Lisa J Strug11, Pierre Lepage9, Jiannis Ragoussis7,9, Guillaume Bourque7,10,9, Jahad Alghamdi, Nora Aljawini12, Nour Albes12, Hani M Al-Afghani13, Bader Alghamdi5, Mansour S Almutairi5, Ebrahim Sabri Mahmoud14, Leen Abu-Safieh15, Hadeel El Bardisy15, Fawz S Al Harthi15, Abdulraheem Alshareef16, Bandar Ali Suliman16, Saleh A Alqahtani17,18, Abdulaziz Almalik19, May M Alrashed20, Salam Massadeh5,6, Vincent Mooser7, Mark Lathrop7,11,9, Mohamed Fawzy15, Yaseen M Arabi14, Hamdi Mbarek21, Chadi Saad21, Wadha Al-Muftah21, Junghyun Jung22,23, Serghei Mangul22, Radja Badji21, Asma Al Thani21, Said I Ismail21, Ali G Gharavi1,4,24, Malak S Abedalthagafi15, J Brent Richards2,3,8,25, David B Goldstein1,26, Krzysztof Kiryluk1,4.   

Abstract

A recent report found that rare predicted loss-of-function (pLOF) variants across 13 candidate genes in TLR3- and IRF7-dependent type I IFN pathways explain up to 3.5% of severe COVID-19 cases. We performed whole-exome or whole-genome sequencing of 1,864 COVID-19 cases (713 with severe and 1,151 with mild disease) and 15,033 ancestry-matched population controls across 4 independent COVID-19 biobanks. We tested whether rare pLOF variants in these 13 genes were associated with severe COVID-19. We identified only 1 rare pLOF mutation across these genes among 713 cases with severe COVID-19 and observed no enrichment of pLOFs in severe cases compared to population controls or mild COVID-19 cases. We found no evidence of association of rare LOF variants in the 13 candidate genes with severe COVID-19 outcomes.

Entities:  

Keywords:  Genetic variation; Genetics; Infectious disease

Year:  2021        PMID: 34043590     DOI: 10.1172/JCI147834

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  22 in total

1.  The Journal of Clinical Investigation in the time of COVID-19.

Authors:  Arturo Casadevall; Sarah Jackson; Gregg L Semenza; Gordon F Tomaselli; Rexford S Ahima
Journal:  J Clin Invest       Date:  2021-12-15       Impact factor: 14.808

Review 2.  Mechanisms of Immune Dysregulation in COVID-19 Are Different From SARS and MERS: A Perspective in Context of Kawasaki Disease and MIS-C.

Authors:  Manpreet Dhaliwal; Rahul Tyagi; Pooja Malhotra; Prabal Barman; Sathish Kumar Loganathan; Jyoti Sharma; Kaushal Sharma; Sanjib Mondal; Amit Rawat; Surjit Singh
Journal:  Front Pediatr       Date:  2022-05-05       Impact factor: 3.569

Review 3.  The human genetic epidemiology of COVID-19.

Authors:  Mari E K Niemi; Mark J Daly; Andrea Ganna
Journal:  Nat Rev Genet       Date:  2022-05-02       Impact factor: 59.581

Review 4.  Interfering with SARS-CoV-2: are interferons friends or foes in COVID-19?

Authors:  Ivan Zanoni
Journal:  Curr Opin Virol       Date:  2021-08-17       Impact factor: 7.090

5.  Do monogenic inborn errors of immunity cause susceptibility to severe COVID-19?

Authors:  Chris Cotsapas; Janna Saarela; Jocelyn R Farmer; Vinod Scaria; Roshini S Abraham
Journal:  J Clin Invest       Date:  2021-07-15       Impact factor: 19.456

Review 6.  SARS-CoV-2 infections in children: Understanding diverse outcomes.

Authors:  Petter Brodin
Journal:  Immunity       Date:  2022-01-20       Impact factor: 31.745

7.  Pan-ancestry exome-wide association analyses of COVID-19 outcomes in 586,157 individuals.

Authors:  Jack A Kosmicki; Julie E Horowitz; Nilanjana Banerjee; Rouel Lanche; Anthony Marcketta; Evan Maxwell; Xiaodong Bai; Dylan Sun; Joshua D Backman; Deepika Sharma; Fabricio S P Kury; Hyun M Kang; Colm O'Dushlaine; Ashish Yadav; Adam J Mansfield; Alexander H Li; Kyoko Watanabe; Lauren Gurski; Shane E McCarthy; Adam E Locke; Shareef Khalid; Sean O'Keeffe; Joelle Mbatchou; Olympe Chazara; Yunfeng Huang; Erika Kvikstad; Amanda O'Neill; Paul Nioi; Meg M Parker; Slavé Petrovski; Heiko Runz; Joseph D Szustakowski; Quanli Wang; Emily Wong; Aldo Cordova-Palomera; Erin N Smith; Sandor Szalma; Xiuwen Zheng; Sahar Esmaeeli; Justin W Davis; Yi-Pin Lai; Xing Chen; Anne E Justice; Joseph B Leader; Tooraj Mirshahi; David J Carey; Anurag Verma; Giorgio Sirugo; Marylyn D Ritchie; Daniel J Rader; Gundula Povysil; David B Goldstein; Krzysztof Kiryluk; Erola Pairo-Castineira; Konrad Rawlik; Dorota Pasko; Susan Walker; Alison Meynert; Athanasios Kousathanas; Loukas Moutsianas; Albert Tenesa; Mark Caulfield; Richard Scott; James F Wilson; J Kenneth Baillie; Guillaume Butler-Laporte; Tomoko Nakanishi; Mark Lathrop; J Brent Richards; Marcus Jones; Suganthi Balasubramanian; William Salerno; Alan R Shuldiner; Jonathan Marchini; John D Overton; Lukas Habegger; Michael N Cantor; Jeffrey G Reid; Aris Baras; Goncalo R Abecasis; Manuel A R Ferreira
Journal:  Am J Hum Genet       Date:  2021-06-03       Impact factor: 11.043

8.  Association of rare predicted loss-of-function variants of influenza-related type I IFN genes with critical COVID-19 pneumonia. Reply.

Authors:  Gundula Povysil; Guillaume Butler-Laporte; Ali G Gharavi; J Brent Richards; David B Goldstein; Krzysztof Kiryluk
Journal:  J Clin Invest       Date:  2021-08-02       Impact factor: 19.456

9.  Association of rare predicted loss-of-function variants of influenza-related type I IFN genes with critical COVID-19 pneumonia.

Authors:  Qian Zhang; Aurélie Cobat; Paul Bastard; Luigi D Notarangelo; Helen C Su; Laurent Abel; Jean-Laurent Casanova
Journal:  J Clin Invest       Date:  2021-08-02       Impact factor: 19.456

10.  Mapping the human genetic architecture of COVID-19.

Authors: 
Journal:  Nature       Date:  2021-07-08       Impact factor: 69.504

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.